GlassScriptPhysician profile
Juddson T Chason
NPI 1376668228
$19,865.95
in general payments reported to CMS, 2019-2025
40 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,308 · 2020: $909 · 2021: $2,058 · 2022: $11K · 2023: $2,552 · 2024: $989 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,198 · Travel and Lodging: $1,021 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,197.71 |
| Travel and Lodging | $1,021.05 |
| Education | $399.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,910.22 | 2019-2025 | Ams 700, Axonics, Rezum Generator |
| Astellas Pharma US INC | $2,069.41 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $832.66 | 2019-2025 | Erleada |
| Pfizer INC. | $819.43 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $548.13 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $447.47 | 2019-2025 | Botox, Lupron Depot |
| Ethicon US, LLC | $365.66 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $325.31 | 2019-2025 | |
| Hollister Incorporated | $315.02 | 2021-2023 | Onli, Infyna Chic, Vapro |
| Myovant Sciences INC. | $312.81 | 2021-2022 | |
| Tolmar, INC. | $250.48 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $209.74 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Tolmar Pharmaceuticals, INC. | $198.62 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $119.29 | 2022-2025 | Bard Urinary Drainage Bag, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Axonics, INC. | $112.81 | 2023-2024 | Axonics, Bulkamid |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $104.99 | 2021-2022 | |
| Blue Earth Diagnostics | $101.76 | 2020-2022 | |
| Procept Biorobotics Corporation | $100.00 | 2024 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $87.84 | 2024-2025 | Adstiladrin |
| Amgen INC. | $79.11 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $79.07 | 2022-2023 | Seglentis |
| Dentsply Ih INC. | $49.76 | 2020-2021 | |
| Olympus America INC. | $40.73 | 2022-2025 | Itind System |
| Endo Pharmaceuticals INC. | $40.62 | 2019-2023 | Xiaflex |
| Palette Life Sciences, INC. | $39.98 | 2023 | |
| Neotract INC. | $27.22 | 2019 | |
| Coloplast Corp | $26.93 | 2023 | Speedicath |
| Laborie Medical Technologies Corp. | $26.10 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Smith+Nephew, INC. | $21.92 | 2023 | Grafix Pl |
| Dendreon Pharmaceuticals LLC | $20.86 | 2023 | Provenge |
| Argon Medical Devices, INC. | $20.59 | 2023 | Trucore |
| Teleflex LLC | $20.55 | 2023 | Urolift |
| Urogen Pharma, INC. | $20.40 | 2022 | |
| Immunitybio, INC. | $20.28 | 2025 | |
| Alexion Pharmaceuticals, INC. | $19.41 | 2021 | |
| Janssen Scientific Affairs, LLC | $18.40 | 2019 | |
| Medtronic, INC. | $17.57 | 2022 | |
| Kerecis Limited | $17.33 | 2022 | |
| Intuitive Surgical, INC. | $14.07 | 2023-2024 | Da Vinci Surgical System |
| Merz Pharmaceuticals, LLC | $13.40 | 2024 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juddson Chason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.